KK2845

N/A

Report date: 2024/12/12 11:06:38

Base Information

Drug NameKK2845
Drug Alias NameKK2845KK-2845
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsDNA cross linking agents
TargetsDNA
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKyowa Kirin Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKyowa Kirin Co Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A